BionimeTPE:4737 -2.80%65 FCF Yield % is 4.67 as of Jun. 30, 2026. GuruFocus rates TPE:4737 with a GF Score™ of 65/100 and a GF Value™ of NT$58.96 (Fairly Valued). The stock has 7 warning signs investors should review. Among 854 Medical Devices & Instruments companies, Bionime ranks better than 78.57% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
As of today, Bionime's Trailing 12-Month Free Cash Flow is NT$206 Mil, and Market Cap is NT$4,421 Mil. Therefore, Bionime's FCF Yield % for today is 4.67%.
The historical rank and industry rank for Bionime's FCF Yield % or its related term are showing as below:
TPE:4737'
s FCF Yield % Range Over the Past 10 Years
Min: -8.91 Med: -0.51 Max: 14.04
Current: 4.67
During the past 13 years, the highest FCF Yield % of Bionime was 14.04%. The lowest was -8.91%. And the median was -0.51%.
TPE:4737's FCF Yield % is ranked better than 78.57% of 854
companies
in the Medical Devices & Instruments industry
Industry Median: -0.385
vs TPE:4737: 4.67
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Bionime FCF Yield % Related Terms
Bionime FCF Yield % Historical Data
* Premium members only.
The historical data trend for Bionime's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TPE:4737 vs ISRG, BDX, MDLN: FCF Yield % Comparison
For the Medical Instruments & Supplies subindustry, Bionime's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bionime FCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Bionime's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Bionime's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bionime (TPE:4737) has a FCF Yield % of 4.67 as of Jun. 30, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Bionime and its competitors. According to the industry distribution chart, Bionime ranks #183 out of 854 companies in the Medical Devices & Instruments industry, placing it in the top 21.4%.
Is Bionime's FCF Yield % too high?
Bionime's current FCF Yield % is 4.67. Based on the distribution chart, Bionime ranks #183 out of 854 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Bionime has a GF Score™ of 65/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Bionime's FCF Yield % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Bionime ranks #183 out of 854 companies for FCF Yield %. This places Bionime in the top 21% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Medical Devices & Instruments company?
A good FCF Yield % depends on the Medical Devices & Instruments industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Bionime and its competitors. Bionime's current FCF Yield % is 4.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bionime stock overvalued right now?
Based on GuruFocus' analysis, Bionime (TPE:4737) is currently considered Fairly Valued. The stock's GF Value™ is NT$58.96, compared to a current price of NT$55.60 — trading 5.7% below its estimated fair value. The current FCF Yield % is 4.67. Bionime's overall GF Score™ is 65/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Bionime (TPE:4737), the current FCF Yield % is 4.67 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bionime (TPE:4737) Overvalued in 2026?
Based on GuruFocus' analysis, Bionime stock appears to be undervalued.
The current stock price of NT$55.60 is trading 5.7% below its estimated GF Value™ of NT$58.96.
GuruFocus considers Bionime to be Fairly Valued.
Key valuation signals for TPE:4737:
FCF Yield %: 4.67
GF Value™: NT$58.96 vs. price of NT$55.60 (5.7% below fair value)
No single metric tells the full story. See the TPE:4737 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bionime Corp is engaged in the manufacturing and selling of medical instruments, providing biotechnology services, examining pharmaceuticals, and selling precision instruments. The company's revenue is derived from the sale of blood glucose meters and test strips to domestic and foreign clients. Geographically, it operates in Algeria, China, Switzerland, the United States, Belarus, Egypt, the United Arab Emirates, and other countries, of which it derives the maximum revenue from Algeria.
65GF Score
Get the complete analysis for TPE:4737
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:4737 has been successfully added to your 
